Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2679 of 5804
-
New breast cancer drug trial halted early – what we know
Disease control TerminatedThis is an open-label, Phase 2 study to evaluate preliminary anti-tumor activity, safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of BDC-1001 administered as a single agent and in combination with pertuzumab in subjects with human epidermal …
Phase: PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Eye membrane patch shows promise for blinding corneal disease
Disease control CompletedLimbal Stem Cell Deficiency (LSCD) is a blinding disease that accounts for an estimated 15-20% of corneal blindness worldwide. Current treatments are limited. Traditional corneal transplantation with penetrating keratoplasty (PKP) is ineffective in treating these patients. Withou…
Phase: PHASE1 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Diet study aims to boost brain health in rural seniors
Disease control CompletedObjective 1: To scale-up the nutrition adherence intervention for testing in racially diverse rural communities in North Florida. The investigators hypothesize that: 1\. The protocol will produce at least 75% of participants obtaining measurable levels of urine ketones (e.g., g…
Phase: NA • Sponsor: Florida State University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Digital coaching eases cancer treatment struggles
Symptom relief CompletedBrief Summary This study evaluates the effectiveness of a structured eHealth-based educational and support intervention in improving self-management practices and psychological coping behaviors among adult cancer patients. Using a quasi-experimental pretest-posttest design with s…
Phase: NA • Sponsor: Zagazig University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New study aims to uncover hidden health risks in down syndrome leukemia survivors
Knowledge-focused Recruiting nowThis study attempts to learn more about the health of persons with Down syndrome after treatment for acute leukemia. Children with Down syndrome are at increased risk for side effects during treatment for acute leukemia, but it is unclear of their risk for long-term effects of ca…
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New swallowing therapy aims to help stroke survivors eat safely again
Symptom relief ENROLLING_BY_INVITATIONThe purpose of this study is to determine a standardized protocol for swallowing therapy and this protocol's effects on recovery after a stroke
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New Parkinson's drug ABBV-951 under Real-World watch in japan
Disease control OngoingParkinson's disease (PD) is a neurological condition, which affects the brain. Some symptoms of PD are tremors, stiffness, and slowness of movement. The purpose of this study is to assess how safe and effective ABBV-951 is in treating participants with Parkinson's disease in real…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New implant aims to prevent repeat disc herniations
Disease control Recruiting nowThe goal of this clinical investigation is to learn about DISC Care, an Hernia Blocking System, in patients who have undergone lumbar disc hernia surgery. The main questions it aims to answer are: * if the implant (DISC Care) prevents disc herniation recurrence * if DISC Care is…
Phase: NA • Sponsor: NEOS Surgery • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Experimental drug combo for rare sarcoma shows promise, but trial halted early
Disease control TerminatedTo compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.
Phase: PHASE3 • Sponsor: Polaris Group • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a hope program lift spirits during lung cancer treatment?
Symptom relief Recruiting nowThis study will compare the effects of a brief supportive intervention, called Pathways, against enhanced usual care on the mental health and quality of life of people undergoing treatment for advanced lung cancer. Patients will complete baseline survey measures and be randomized…
Phase: NA • Sponsor: Laurie McLouth • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Laser treatment shows promise for easing knee arthritis pain
Symptom relief CompletedThe goal of this clinical trial was to determine whether high-intensity laser therapy (HILT) combined with exercise improves pain, physical function, and muscle strength in people with knee osteoarthritis. The main questions the study aimed to answer were: * Did HILT combined w…
Phase: NA • Sponsor: Universidad Metropolitana de Ciencias de la Educacion • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Gut bacteria may hold key to weight loss — trial puts probiotic to the test
Disease control CompletedThe goal of this study is to investigate the effects of Bifidobacterium longum subspecies BL21 on BMI, metabolic indicators, and changes in gut microenvironment microbiota in overweight/obese adults. The blood, urine, and feces samples of the subjects need to be collected at 0,4…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug LX9211 aims to ease diabetic nerve pain
Symptom relief CompletedEvaluation of the efficacy of LX9211 compared to placebo in reducing DPNP. Please see study website: https://diabeticpainstudy.com/
Phase: PHASE2 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New home device aims to treat erectile dysfunction without drugs
Symptom relief OngoingAdult subjects with mild to moderate and moderate ED who meet the study eligibility criteria will be enrolled in the study. The enrolled subjects will be randomized by a 1:1 ratio to receive the Active or Sham VERTICA® treatment. Baseline assessments will include collection of de…
Phase: NA • Sponsor: OHH-MED Medical Ltd • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Soundwave therapy shows promise for chemo nerve damage
Symptom relief OngoingThe goal of this clinical trial is to assess the efficacy of SensoniQ® Treatment Station in preventing or reducing chemotherapy induced peripheral neuropathy symptoms (CIPNS) in patients receiving frontline carboplatin and paclitaxel chemotherapy for a gynecologic malignancy. Thi…
Phase: NA • Sponsor: Augusta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can VR help seniors recover from concussions?
Symptom relief CompletedTraumatic brain injury (TBI) is a major public health concern, particularly among older adults (OAs) ≥ 65 years of age. Each year in the United States, TBI results in over 600,000 emergency department visits and hospitalizations among OAs. Mild TBI (mTBI) accounts for 80% of all …
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New drug cocktail aims to fight stomach cancer in the abdomen
Disease control OngoingThis phase Ib trial test effects of aldesleukin in combination with nivolumab and standard chemotherapy in treating patients with gastric cancer that has spread to the tissue lining of the abdomen (peritoneal metastasis). Aldesleukin is similar to a protein that naturally exists …
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help surgeons avoid nerve damage
Symptom relief CompletedA Part 1 Phase 2 feasibility study to characterize the feasibility of using the REVEAL 475 system by obtaining surgeon perspective on illumination and ease of use. A Part 2 Phase 3 safety and efficacy study to evaluate conspicuity of the identified nerve due to bevonescein throu…
Phase: PHASE2, PHASE3 • Sponsor: Alume Biosciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New CGM algorithm could simplify insulin dosing for diabetes
Disease control CompletedThe goal of this clinical trial is to compare the effect of a continuous glucose monitor (CGM) based titration algorithm to standard titration by self-monitoring blood glucose (SMBG) in participants with Type 2 Diabetes already using long acting insulin. The comparison aims to st…
Phase: NA • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can better sleep ease Crohn's symptoms? new study investigates
Symptom relief OngoingThe purpose of this study is to assess whether the investigators can treat insomnia in people with Crohn's disease, and if insomnia treatment can make other things better, like pain or inflammation.
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC